SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-147635
Filing Date
2023-05-18
Accepted
2023-05-18 07:45:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d435309d424b5.htm 424B5 365528
2 EX-FILING FEES d435309dexfilingfees.htm EX-FILING FEES 31213
3 GRAPHIC g435309g00b01.jpg GRAPHIC 18744
  Complete submission text file 0001193125-23-147635.txt   423683
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258634 | Film No.: 23933721
SIC: 2834 Pharmaceutical Preparations